One evolving metabolic record
Weight, labs, wearables and symptoms in a single longitudinal story.
Beyond weight loss — the journey that keeps you on track.
A GLP-1 brings weight loss and better blood sugar — but also shifts in energy, mood and muscle, and a hard truth: most people stop within the first year. StoryMD connects labs, wearables and symptoms into one evolving story, so the journey is guided, understood and sustained.
50–75%
of people discontinue a GLP-1 within the first year
JAMA Network Open
1 record
labs, wearables and symptoms, connected over time
Beyond
weight — energy, mood, muscle and metabolic health
Persistence is the whole game.
GLP-1s are the fastest-growing drug class in a generation. Their defining weakness isn't efficacy — it's persistence. Cost, side effects, plateaus and lost access drive people off therapy, and the benefit stops when they do. Most of that drop-off happens quietly, between appointments.
StoryMD connects your labs, wearables and symptoms into one evolving story — tracking the weight, biomarkers, side effects and behavior that predict when someone is about to fall off, and giving them the guidance to stay on. It's personalized metabolic care, not a one-time prescription.
The GLP-1 journey, tracked end to end.
Every stage of treatment brings its own reasons to stop. StoryMD follows each one from the first dose to long-term maintenance, capturing the signals that predict drop-off as they happen.
- 01
Start
Baseline labs, weight and goals, recorded before the first dose.
- 02
Titration
Side effects tracked as the dose climbs, with guidance to ease them.
- 03
Plateau
Behavior and nutrition reviewed when the scale stops moving.
- 04
Adherence
Support that arrives when engagement dips, before someone quits.
- 05
Maintenance
Metabolic health followed long after the weight goal is reached.
Everything that keeps treatment on track.
One record that connects what someone feels with what their labs show, so the signals of drop-off surface while there is still time to act.
Labs + wearables + symptoms, connected
The full picture no single tracker or portal can assemble.
Side-effect & persistence tracking
The early signals of drop-off, surfaced before someone quits.
GLP-1 journey & explainer
A live, visual guide to what the medication does — and why.
Weight loss you can finally see.
A few of the images in the StoryMD library on weight loss. Open any one to see it full size.
Keep patients on therapy — and prove it.
The same longitudinal record that helps a person stay on track becomes consented, real-world evidence of persistence and outcomes — the exact asset GLP-1 manufacturers and payers cannot get anywhere else. The subscription opens the door; the evidence is the lasting value.